Global Metal Powder for 3D Printing Market
As the global economy mends, the 2021 growth of Metal Powder for 3D Printing will have significan ... Read More
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global mRNA Vaccines & Therapeutics Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Country/Region, 2017, 2022 & 2028 2.2 mRNA Vaccines & Therapeutics Segment by Type 2.2.1 Infectious Disease Vaccines 2.2.2 Cancer Vaccines 2.3 mRNA Vaccines & Therapeutics Sales by Type 2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022) 2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2017-2022) 2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2017-2022) 2.4 mRNA Vaccines & Therapeutics Segment by Application 2.4.1 Infectious Disease 2.4.2 Cancer 2.5 mRNA Vaccines & Therapeutics Sales by Application 2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2017-2022) 2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2017-2022) 2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2017-2022) 3 Global mRNA Vaccines & Therapeutics by Company 3.1 Global mRNA Vaccines & Therapeutics Breakdown Data by Company 3.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Company (2020-2022) 3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2022) 3.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Company (2020-2022) 3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2020-2022) 3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2022) 3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company 3.4 Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution 3.4.2 Players mRNA Vaccines & Therapeutics Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for mRNA Vaccines & Therapeutics by Geographic Region 4.1 World Historic mRNA Vaccines & Therapeutics Market Size by Geographic Region (2017-2022) 4.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Geographic Region (2017-2022) 4.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Geographic Region 4.2 World Historic mRNA Vaccines & Therapeutics Market Size by Country/Region (2017-2022) 4.2.1 Global mRNA Vaccines & Therapeutics Annual Sales by Country/Region (2017-2022) 4.2.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Country/Region 4.3 Americas mRNA Vaccines & Therapeutics Sales Growth 4.4 APAC mRNA Vaccines & Therapeutics Sales Growth 4.5 Europe mRNA Vaccines & Therapeutics Sales Growth 4.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth 5 Americas 5.1 Americas mRNA Vaccines & Therapeutics Sales by Country 5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2017-2022) 5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) 5.2 Americas mRNA Vaccines & Therapeutics Sales by Type 5.3 Americas mRNA Vaccines & Therapeutics Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC mRNA Vaccines & Therapeutics Sales by Region 6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2017-2022) 6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) 6.2 APAC mRNA Vaccines & Therapeutics Sales by Type 6.3 APAC mRNA Vaccines & Therapeutics Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe mRNA Vaccines & Therapeutics by Country 7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2022) 7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) 7.2 Europe mRNA Vaccines & Therapeutics Sales by Type 7.3 Europe mRNA Vaccines & Therapeutics Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country 8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2022) 8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) 8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type 8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics 10.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics 10.4 Industry Chain Structure of mRNA Vaccines & Therapeutics 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 mRNA Vaccines & Therapeutics Distributors 11.3 mRNA Vaccines & Therapeutics Customer 12 World Forecast Review for mRNA Vaccines & Therapeutics by Geographic Region 12.1 Global mRNA Vaccines & Therapeutics Market Size Forecast by Region 12.1.1 Global mRNA Vaccines & Therapeutics Forecast by Region (2023-2028) 12.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global mRNA Vaccines & Therapeutics Forecast by Type 12.7 Global mRNA Vaccines & Therapeutics Forecast by Application 13 Key Players Analysis 13.1 Moderna Therapeutics 13.1.1 Moderna Therapeutics Company Information 13.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered 13.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Moderna Therapeutics Main Business Overview 13.1.5 Moderna Therapeutics Latest Developments 13.2 CureVac 13.2.1 CureVac Company Information 13.2.2 CureVac mRNA Vaccines & Therapeutics Product Offered 13.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 CureVac Main Business Overview 13.2.5 CureVac Latest Developments 13.3 Translate Bio 13.3.1 Translate Bio Company Information 13.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Offered 13.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Translate Bio Main Business Overview 13.3.5 Translate Bio Latest Developments 13.4 BioNTech 13.4.1 BioNTech Company Information 13.4.2 BioNTech mRNA Vaccines & Therapeutics Product Offered 13.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 BioNTech Main Business Overview 13.4.5 BioNTech Latest Developments 13.5 Sangamo Therapeutics 13.5.1 Sangamo Therapeutics Company Information 13.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered 13.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Sangamo Therapeutics Main Business Overview 13.5.5 Sangamo Therapeutics Latest Developments 13.6 Argos Therapeutics 13.6.1 Argos Therapeutics Company Information 13.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered 13.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Argos Therapeutics Main Business Overview 13.6.5 Argos Therapeutics Latest Developments 13.7 In-Cell-Art 13.7.1 In-Cell-Art Company Information 13.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Offered 13.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 In-Cell-Art Main Business Overview 13.7.5 In-Cell-Art Latest Developments 13.8 eTheRNA 13.8.1 eTheRNA Company Information 13.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Offered 13.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 eTheRNA Main Business Overview 13.8.5 eTheRNA Latest Developments 13.9 Ethris 13.9.1 Ethris Company Information 13.9.2 Ethris mRNA Vaccines & Therapeutics Product Offered 13.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Ethris Main Business Overview 13.9.5 Ethris Latest Developments 13.10 Tiba Biotechnology 13.10.1 Tiba Biotechnology Company Information 13.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered 13.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Tiba Biotechnology Main Business Overview 13.10.5 Tiba Biotechnology Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. mRNA Vaccines & Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. mRNA Vaccines & Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Infectious Disease Vaccines Table 4. Major Players of Cancer Vaccines Table 5. Global mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses) Table 6. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022) Table 7. Global mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & ($ million) Table 8. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2022) Table 9. Global mRNA Vaccines & Therapeutics Sale Price by Type (2017-2022) & (USD/Doses) Table 10. Global mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses) Table 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022) Table 12. Global mRNA Vaccines & Therapeutics Revenue by Application (2017-2022) Table 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2022) Table 14. Global mRNA Vaccines & Therapeutics Sale Price by Application (2017-2022) & (USD/Doses) Table 15. Global mRNA Vaccines & Therapeutics Sales by Company (2020-2022) & (M Doses) Table 16. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2022) Table 17. Global mRNA Vaccines & Therapeutics Revenue by Company (2020-2022) ($ Millions) Table 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2022) Table 19. Global mRNA Vaccines & Therapeutics Sale Price by Company (2020-2022) & (USD/Doses) Table 20. Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution and Sales Area Table 21. Players mRNA Vaccines & Therapeutics Products Offered Table 22. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global mRNA Vaccines & Therapeutics Sales by Geographic Region (2017-2022) & (M Doses) Table 26. Global mRNA Vaccines & Therapeutics Sales Market Share Geographic Region (2017-2022) Table 27. Global mRNA Vaccines & Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global mRNA Vaccines & Therapeutics Revenue Market Share by Geographic Region (2017-2022) Table 29. Global mRNA Vaccines & Therapeutics Sales by Country/Region (2017-2022) & (M Doses) Table 30. Global mRNA Vaccines & Therapeutics Sales Market Share by Country/Region (2017-2022) Table 31. Global mRNA Vaccines & Therapeutics Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global mRNA Vaccines & Therapeutics Revenue Market Share by Country/Region (2017-2022) Table 33. Americas mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses) Table 34. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2022) Table 35. Americas mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2022) Table 37. Americas mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses) Table 38. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022) Table 39. Americas mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses) Table 40. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022) Table 41. APAC mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses) Table 42. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2022) Table 43. APAC mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Region (2017-2022) Table 45. APAC mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses) Table 46. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022) Table 47. APAC mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses) Table 48. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022) Table 49. Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses) Table 50. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2022) Table 51. Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2022) Table 53. Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses) Table 54. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022) Table 55. Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses) Table 56. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses) Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses) Table 62. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses) Table 64. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of mRNA Vaccines & Therapeutics Table 66. Key Market Challenges & Risks of mRNA Vaccines & Therapeutics Table 67. Key Industry Trends of mRNA Vaccines & Therapeutics Table 68. mRNA Vaccines & Therapeutics Raw Material Table 69. Key Suppliers of Raw Materials Table 70. mRNA Vaccines & Therapeutics Distributors List Table 71. mRNA Vaccines & Therapeutics Customer List Table 72. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2023-2028) & (M Doses) Table 73. Global mRNA Vaccines & Therapeutics Sales Market Forecast by Region Table 74. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas mRNA Vaccines & Therapeutics Sales Forecast by Country (2023-2028) & (M Doses) Table 77. Americas mRNA Vaccines & Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC mRNA Vaccines & Therapeutics Sales Forecast by Region (2023-2028) & (M Doses) Table 79. APAC mRNA Vaccines & Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2023-2028) & (M Doses) Table 81. Europe mRNA Vaccines & Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2023-2028) & (M Doses) Table 83. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2023-2028) & (M Doses) Table 85. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2023-2028) Table 86. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2023-2028) Table 88. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2023-2028) & (M Doses) Table 89. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2023-2028) Table 90. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2023-2028) Table 92. Moderna Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 93. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 94. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 95. Moderna Therapeutics Main Business Table 96. Moderna Therapeutics Latest Developments Table 97. CureVac Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 98. CureVac mRNA Vaccines & Therapeutics Product Offered Table 99. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 100. CureVac Main Business Table 101. CureVac Latest Developments Table 102. Translate Bio Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 103. Translate Bio mRNA Vaccines & Therapeutics Product Offered Table 104. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 105. Translate Bio Main Business Table 106. Translate Bio Latest Developments Table 107. BioNTech Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 108. BioNTech mRNA Vaccines & Therapeutics Product Offered Table 109. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 110. BioNTech Main Business Table 111. BioNTech Latest Developments Table 112. Sangamo Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 113. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 114. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 115. Sangamo Therapeutics Main Business Table 116. Sangamo Therapeutics Latest Developments Table 117. Argos Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 118. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 119. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 120. Argos Therapeutics Main Business Table 121. Argos Therapeutics Latest Developments Table 122. In-Cell-Art Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 123. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered Table 124. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 125. In-Cell-Art Main Business Table 126. In-Cell-Art Latest Developments Table 127. eTheRNA Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 128. eTheRNA mRNA Vaccines & Therapeutics Product Offered Table 129. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 130. eTheRNA Main Business Table 131. eTheRNA Latest Developments Table 132. Ethris Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 133. Ethris mRNA Vaccines & Therapeutics Product Offered Table 134. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 135. Ethris Main Business Table 136. Ethris Latest Developments Table 137. Tiba Biotechnology Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 138. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered Table 139. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 140. Tiba Biotechnology Main Business Table 141. Tiba Biotechnology Latest Developments List of Figures Figure 1. Picture of mRNA Vaccines & Therapeutics Figure 2. mRNA Vaccines & Therapeutics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global mRNA Vaccines & Therapeutics Sales Growth Rate 2017-2028 (M Doses) Figure 7. Global mRNA Vaccines & Therapeutics Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. mRNA Vaccines & Therapeutics Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Infectious Disease Vaccines Figure 10. Product Picture of Cancer Vaccines Figure 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2021 Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2022) Figure 13. mRNA Vaccines & Therapeutics Consumed in Infectious Disease Figure 14. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2017-2022) & (M Doses) Figure 15. mRNA Vaccines & Therapeutics Consumed in Cancer Figure 16. Global mRNA Vaccines & Therapeutics Market: Cancer (2017-2022) & (M Doses) Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022) Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2021 Figure 19. mRNA Vaccines & Therapeutics Revenue Market by Company in 2021 ($ Million) Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2021 Figure 21. Global mRNA Vaccines & Therapeutics Sales Market Share by Geographic Region (2017-2022) Figure 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Geographic Region in 2021 Figure 23. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2022) Figure 24. Global mRNA Vaccines & Therapeutics Revenue Market Share by Country/Region in 2021 Figure 25. Americas mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses) Figure 26. Americas mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions) Figure 27. APAC mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses) Figure 28. APAC mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions) Figure 29. Europe mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses) Figure 30. Europe mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions) Figure 31. Middle East & Africa mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses) Figure 32. Middle East & Africa mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions) Figure 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country in 2021 Figure 34. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2021 Figure 35. United States mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 36. Canada mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 37. Mexico mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 38. Brazil mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 39. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region in 2021 Figure 40. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2021 Figure 41. China mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 42. Japan mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 43. South Korea mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 44. Southeast Asia mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 45. India mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 46. Australia mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 47. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2021 Figure 48. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2021 Figure 49. Germany mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 50. France mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 51. UK mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 52. Italy mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 53. Russia mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 54. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2021 Figure 55. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2021 Figure 56. Egypt mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 57. South Africa mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 58. Israel mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 59. Turkey mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 60. GCC Country mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions) Figure 61. Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics in 2021 Figure 62. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics Figure 63. Industry Chain Structure of mRNA Vaccines & Therapeutics Figure 64. Channels of Distribution Figure 65. Distributors Profiles
As the global economy mends, the 2021 growth of Metal Powder for 3D Printing will have significan ... Read More
As the global economy mends, the 2021 growth of Solar Cell (Photovoltaic) Module will have signif ... Read More
As the global economy mends, the 2021 growth of Airborne Radars will have significant change from ... Read More
As the global economy mends, the 2021 growth of Logging Tools will have significant change from p ... Read More